XBIT vs. IHI

In the year-to-date period, XBIT achieves a -29.87% return, which is significantly lower than IHI's 4.18% return. Over the past 10 years, XBIT has underperformed IHI with an annualized return of -17.06%, while IHI has yielded a comparatively higher 12.59% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XBIT Sharpe Ratio is -0.84, which is lower than the IHI Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of XBIT and IHI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

XBIT has not paid dividends to shareholders, while IHI's dividend yield for the trailing twelve months is around 0.45%.

The maximum XBIT drawdown since its inception was -92.67%, which is greater than IHI's maximum drawdown of -49.64%. Use the drawdown chart below to compare losses from any high point for XBIT and IHI. For additional features, visit the drawdowns tool.

XBiotech Inc. (XBIT) has a higher volatility of 25.41% compared to iShares U.S. Medical Devices ETF (IHI) at 6.41%. This indicates that XBIT's price experiences larger fluctuations and is considered to be riskier than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.